Abstract:Abstract Background Single-cell transcriptomic data of the human intestine has shed new light on the cellular composition and heterogeneity present in healthy and diseased tissues. Nonetheless, little information is currently available on their spatial distribution within tissue structures and cellular neighborhoods, which is particularly relevant to infer the function of disease-specific cell types. Here, we apply spatial transcriptomics to healthy control (HC) and Crohn’s disease (CD) intestinal samples and provide a map of cell types across healthy and diseased colon. Methods Fresh frozen colonic sections from HC (n=1) and CD (n=3) patients were placed onto 10X Visium slides, which feature thousands of spatially barcoded spots, each capable of capturing RNA from 10-15 cells. To retrieve single-cell resolution, spots were deconvoluted according to the Cell2location approach using our previously generated human single cell RNA sequencing (scRNAseq) dataset1 as a reference. For validation and further analysis at single-cell resolution, a panel of 100 genes was measured using single molecule fluorescent in situ hybridization (Molecular Cartography) (Fig. 1A). Results Deconvolution analysis revealed the cellular composition of each spot across all four different tissue sections including epithelial, stromal and immune cell types. Here, we focused on studying the location and diversity of fibroblasts and macrophages given their plasticity during inflammation1,2. The most abundant fibroblast cell type in CD were the inflammation-associate (IAFs) and the GREM1+ subepithelial fibroblasts. These two subsets showed a distinct gene signature and location, suggesting different functions (Fig. 1B). Most GREM1+ fibroblasts co-expressed FGFR1 and were in proximity with endothelial cells (VWF+) expressing the VEGF receptor 2 KDR, highlighting a potential pro-angiogenic role of GREM1+ fibroblasts3 (Fig. 1C). Remarkably, GREM1 was abundantly expressed by CCL19+ fibroblastic reticular cells and TNC+ stromal cells, underlying the potential heterogeneity of GREM1+ fibroblasts. Regarding macrophages, we could identify an inflammation-specific population expressing PLA2G2D and PTGDS. These macrophages were mainly localized within granulomas surrounding M1 macrophages (Fig. 1D). While their function is unknown, their signature suggests they might be modulating inflammation through the production of anti-inflammatory lipid mediators4. Conclusion Using two different ST technologies, we resolved the tissue distribution of cell populations previously identified by scRNAseq and reveal their potential function based on their spatial location.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: in the colonic tissue of Crohn's Disease (CD), the spatial distribution and functional characteristics of pathological fibroblasts and macrophage populations. Specifically, the researchers hope to reveal the specific locations, diversities, and potential functions of these cell populations in healthy and diseased states through spatial transcriptomics techniques. ### Background Single - cell transcriptomics data has provided new insights into the cell composition and heterogeneity of the human intestine, but currently, very little is known about the spatial distribution of these cells in tissue structures and cell neighborhoods. This spatial information is particularly important for inferring the functions of disease - specific cell types. Therefore, the researchers applied spatial transcriptomics techniques to analyze colon samples from healthy controls (HC) and Crohn's disease patients and mapped the distribution of cell types in healthy and diseased colons. ### Methods The researchers used the 10X Visium platform to perform spatial transcriptomics analysis on freshly frozen colon sections and deconvolved each spatial barcode point into single - cell resolution by the Cell2location method. In addition, single - molecule fluorescence in - situ hybridization (Molecular Cartography) technology was also used to verify and further analyze 100 genes. ### Results The deconvolution analysis revealed the cell composition of each point in all four different tissue sections, including epithelial cells, stromal cells, and immune cells. The research focused on the location and diversity of fibroblasts and macrophages: - **Fibroblasts**: In Crohn's disease patients, the most abundant fibroblast types are inflammation - related fibroblasts (IAFs) and GREM1+ subepithelial fibroblasts. These two subtypes show different gene expression characteristics and locations, suggesting that they may have different functions. - GREM1+ fibroblasts mainly co - express FGFR1 and are close to endothelial cells (VWF+) expressing VEGF receptor 2 (KDR), indicating that GREM1+ fibroblasts may have a role in promoting angiogenesis. - GREM1 is also highly expressed by CCL19+ fibroblastic reticular cells and TNC+ stromal cells, highlighting the potential heterogeneity of GREM1+ fibroblasts. - **Macrophages**: The researchers identified an inflammation - specific macrophage population expressing PLA2G2D and PTGDS. These macrophages are mainly located in granulomas surrounding M1 macrophages. Although their specific functions are still unclear, their gene expression characteristics suggest that they may regulate the inflammatory response by producing anti - inflammatory lipid mediators. ### Conclusion By combining two different spatial transcriptomics techniques, the researchers not only analyzed the distribution of cell populations in tissues previously identified by single - cell RNA sequencing (scRNAseq) but also revealed the potential functions of these cells based on their spatial locations. ### Formulas and Symbols Explanation This article does not involve specific mathematical, physical, or chemical formulas, but mentions the expressions of some genes and proteins, such as: - **GREM1+**: Represents cells expressing the GREM1 gene. - **FGFR1**: Fibroblast growth factor receptor 1. - **VWF+**: Cells expressing von Willebrand factor. - **KDR**: VEGF receptor 2. - **CCL19+**: Cells expressing chemokine CCL19. - **TNC+**: Cells expressing tenascin C. - **PLA2G2D** and **PTGDS**: Genes encoding phospholipase A2 and prostaglandin D synthase respectively. These markers are used to describe cell types and their functional characteristics.

DOP87 Characterization of pathologic fibroblast and macrophage cell populations in colonic Crohn’s Disease with spatial transcriptomics